Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1228559-81-6
2. Linaprazan Glurate [inn]
3. 3vg4d399dt
4. 1-(2-(((8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)carbonyl)amino)ethyl) Pentanedioate
5. Pentanedioic Acid, 1-(2-(((8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)carbonyl)amino)ethyl) Ester
6. Unii-3vg4d399dt
7. 5-(2-(8-((2,6-dimethylbenzyl)amino)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamido)ethoxy)-5-oxopentanoic Acid
8. Glurate De Linaprazan
9. Glurato De Linaprazan
10. Schembl2367993
11. Chembl5095187
12. Glxc-26945
13. Ex-a8505
14. Akos040756559
15. 5-[2-[[8-[(2,6-dimethylphenyl)methylamino]-2,3-dimethylimidazo[1,2-a]pyridine-6-carbonyl]amino]ethoxy]-5-oxopentanoic Acid
16. Da-64980
17. Ms-28939
18. Hy-145578
19. Cs-0376365
20. G79583
21. 5-{2-[(8-{[(2,6-dimethylphenyl)methyl]amino}-2,3-dimethylimidazo[1,2-a]pyridin-6-yl)formamido]ethoxy}-5-oxopentanoic Acid
1. Linaprazan
2. Azd-0865
3. 248919-64-4
4. Azd0865
| Molecular Weight | 480.6 g/mol |
|---|---|
| Molecular Formula | C26H32N4O5 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 12 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 122 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 725 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
43
PharmaCompass offers a list of Linaprazan Glurate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Linaprazan Glurate manufacturer or Linaprazan Glurate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Linaprazan Glurate manufacturer or Linaprazan Glurate supplier.
PharmaCompass also assists you with knowing the Linaprazan Glurate API Price utilized in the formulation of products. Linaprazan Glurate API Price is not always fixed or binding as the Linaprazan Glurate Price is obtained through a variety of data sources. The Linaprazan Glurate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Linaprazan Glurate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Linaprazan Glurate, including repackagers and relabelers. The FDA regulates Linaprazan Glurate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Linaprazan Glurate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Linaprazan Glurate supplier is an individual or a company that provides Linaprazan Glurate active pharmaceutical ingredient (API) or Linaprazan Glurate finished formulations upon request. The Linaprazan Glurate suppliers may include Linaprazan Glurate API manufacturers, exporters, distributors and traders.
Linaprazan Glurate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Linaprazan Glurate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Linaprazan Glurate GMP manufacturer or Linaprazan Glurate GMP API supplier for your needs.
A Linaprazan Glurate CoA (Certificate of Analysis) is a formal document that attests to Linaprazan Glurate's compliance with Linaprazan Glurate specifications and serves as a tool for batch-level quality control.
Linaprazan Glurate CoA mostly includes findings from lab analyses of a specific batch. For each Linaprazan Glurate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Linaprazan Glurate may be tested according to a variety of international standards, such as European Pharmacopoeia (Linaprazan Glurate EP), Linaprazan Glurate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Linaprazan Glurate USP).
